ASH — Ashland Inc. stock price, charts and financials

QT58Ashland Inc.

Ashland Inc. (NYSE: ASH) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
72.32
+0.57+0.79%
ASHQT58Ashland Inc.·NYSE
72.32+0.79%
News
Up 0.8% — Glenmede Trust Co. NA Has $10.64 Million Stake in Ashland Inc. $ASH (defenseworld.net).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E64.00EPS (ttm)1.13Insider Own1.54%Shs Outstand45.79MPerf Week6.34%
Market Cap3.31BForward P/E16.56EPS next Y4.37Insider Trans0.00%Shs Float41.05MPerf Month8.43%
Enterprise Value4.33BPEG3.61EPS next Q1.31Inst Own-Short Float13.87%Perf Quarter37.65%
Income52.00MP/S1.80EPS this Y215.52%Inst Trans-Short Ratio5.56Perf Half Y17.48%
Sales1.84BP/B1.77EPS next Y22.47%ROA1.14%Short Interest5.69MPerf YTD23.27%
Book/sh40.84P/C7.53EPS next 5Y17.75%ROE2.77%52W High74.99 -3.56%Perf Year43.21%
Cash/sh9.61P/FCF10.29EPS past 3/5Y-ROIC1.94%52W Low46.30 56.20%Perf 3Y-21.23%
Dividend Est.1.68 (2.32%)EV/EBITDA12.09Sales past 3/5Y-8.63% -1.98%Gross Margin29.35%Volatility3.96% 3.22%Perf 5Y-16.14%
Dividend TTM1.67 (2.30%)EV/Sales2.35EPS Y/Y TTM-66.57%Oper. Margin7.33%ATR (14)2.46Perf 10Y21.79%
Dividend Ex-DateJun 01, 2026Quick Ratio1.89Sales Y/Y TTM-12.78%Profit Margin2.82%RSI (14)66.66Recom2.33
Dividend Gr. 3/5Y8.13% 8.45%Current Ratio3.05EPS Q/Q-8.08%SMA205.73%Beta0.39Target Price74.13
Payout146.15%Debt/Eq0.83Sales Q/Q7.34%SMA5011.65%Rel Volume0.53Prev Close71.75
Employees2,900LT Debt/Eq0.82EarningsNov 03SMA20023.68%Avg Volume1.01MPrice72.32
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.-4.99% -0.74%Net Debt/EBITDA2.89Volume539,610Change0.79%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-31-26ReiteratedDeutsche BankBuy$74$85
Jul-30-26ReiteratedUBSBuy$72$83
Jul-29-26ReiteratedMizuhoOutperform$70$77
Jul-29-26ReiteratedBMO CapitalOutperform$71$75
Jul-27-26ReiteratedWolfe Research$110$78
Jun-10-26ReiteratedUBSBuy$73$72
May-06-26UpgradeSeaport GlobalNeutralBuy$75
May-04-26ReiteratedMorgan Stanley$63$58
May-01-26ReiteratedDeutsche BankBuy$70$60
Feb-18-26ReiteratedEvercore ISI GroupIn Line$85$62
Latest News
Aug-03-26
Jul-31-26
Jul-30-26
Jul-29-26
Jul-29-2603:04PM
Jul-28-26
Jul-21-26
Jul-14-26
Jul-08-26
Jun-30-26
Company

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
9/30/2025
FY 2024
9/30/2024
FY 2023
9/30/2023
FY 2022
9/30/2022
FY 2021
9/30/2021
FY 2020
9/30/2020
FY 2019
9/30/2019
FY 2018
9/30/2018
Total Revenue1,8431,8242,1132,1912,3912,1112,0162,1482,589
Cost of Goods Sold Incl. D&A1,3021,2751,4951,5231,5611,4411,4171,4971,726
Gross Profit541549618668830670599651863
Selling, General and Administrative Excl. Other324345404365393358400426599
Research and Development555455515550565873
Other Operating Expense279251858049706048189
Operating Income135-775-26172333192-46186102
Interest Expense61635357667391114116
Unusual Expense
Non-Operating Income (Expense)51295545-6116-251925
Net Income Before Taxes125-809-24160206135-577-911
Income Taxes5013-223-825-38-2230-8
Consolidated Net Income52-845169178927220-508505114
Net Income From Continuing Operations75-822199168181173-555-3919
Net Income52-845169178927220-508505114
EPS (Recurring)1.14-18.373.453.3617.172.85-8.338.151.84
EPS (Basic, Before Extraordinaries)1.14-18.373.453.3617.172.85-8.338.151.84
EPS (Diluted)1.13-18.373.383.3116.413.66-8.398.031.78
EBITDA358-509303457509448-254382404
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio64.0025.7324.685.7924.359.6047.11
Price To Sales Ratio1.811.212.021.982.143.292.152.262.01
Gross Margin29.3530.1029.2530.4934.7131.7429.7130.3133.33
Operating Margin7.33-42.49-1.237.8513.939.10-22.874.003.94
Net Margin2.82-46.338.008.1238.7710.42-25.2023.514.40
Shares Outstanding464649535478616362
Market Capitalization3,3272,2044,2624,3295,1286,9514,3264,8545,199
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$76.64$68.40$60.16$51.93$43.69 Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MUSA OSAMA MSVP and CTOJul 29 '26Option Exercise57.9611,060641,03730,806Jul 30
Assis Alessandra FaccinSVP and GM, Life SciencesJul 27 '26Option Exercise66.383,215213,4129,099Jul 29
MINICUCCI JAMES P.SVP and GM, Personal CareMay 08 '26Option Exercise55.014,310237,0938,567May 11
Kulkarni Ashish KDirectorJan 21 '26Option Exercise0.004,22602,113Jan 22
NOVO GUILLERMOChair of the Board and CEONov 17 '25Option Exercise49.606,122303,651143,412Nov 19
Drury EileenSVP and Chief HRONov 17 '25Option Exercise49.6056728,1237,881Nov 19
MUSA OSAMA MSVP and CTONov 17 '25Option Exercise49.6097648,41029,875Nov 19
WHITAKER WILLIAMSVP, CFO & PFONov 17 '25Option Exercise49.601075,3072,082Nov 19
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 17 '25Option Exercise49.6023911,8545,095Nov 19
RICHARDSON SAMUELVP, Controller and PAONov 17 '25Option Exercise49.601075,3071,104Nov 19
MUSA OSAMA MSVP and CTONov 14 '25Option Exercise51.512,091107,70729,616Nov 19
MUSA OSAMA MSVP and CTONov 13 '25Option Exercise53.101,39373,96828,002Nov 19
Drury EileenSVP and Chief HRONov 14 '25Option Exercise51.511,29766,8087,917Nov 17
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 14 '25Option Exercise51.511,27665,7275,237Nov 17
WHITAKER WILLIAMSVP, CFO & PFONov 14 '25Option Exercise51.5135618,3382,083Nov 17
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.